v3.26.1
Segments of business and geographic areas - Operating Profit by Segment of Business (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 28, 2026
Jun. 29, 2025
Jun. 28, 2026
Jun. 29, 2025
Segment Reporting [Line Items]        
Restructuring (Note 12) $ 34 $ 64 $ 66 $ 81
Sales to customers (Note 9) 25,310 23,743 49,372 45,636
Cost of products sold 8,051 7,628 16,157 14,985
Selling, marketing and administrative expenses 6,432 5,889 12,466 11,001
Research and development expense 3,653 3,516 7,180 6,741
Other (income) expense, net (331) (107) (625) 7,214
Earnings before provision for taxes on income 6,747 6,491 12,737 20,122
Less: Expense not allocated to segments 679 265 1,245 (6,735)
Acquisition related costs     100 200
Innovative Medicine        
Segment Reporting [Line Items]        
Sales to customers (Note 9) 16,384 15,202 31,810 29,075
Acquisition related costs 100 200    
Innovative Medicine | Separation Related Costs        
Segment Reporting [Line Items]        
Restructuring (Note 12) 200   200  
MedTech        
Segment Reporting [Line Items]        
Sales to customers (Note 9) 8,926 8,541 17,562 16,561
MedTech | Disposal Group, Disposed of Other than by Sale, Not Discontinued Operation, Spinoff        
Segment Reporting [Line Items]        
Other (income) expense, net 300 0 400 0
General Corporate | Talc        
Segment Reporting [Line Items]        
Litigation expense 400   800  
Reversal of fee expense   7,000   7,000
Operating Segments        
Segment Reporting [Line Items]        
Restructuring (Note 12) 276 79 338 134
Earnings before provision for taxes on income 7,426 6,756 13,982 13,387
Operating Segments | Innovative Medicine        
Segment Reporting [Line Items]        
Restructuring (Note 12) 200 0 200 0
Sales to customers (Note 9) 16,384 15,202 31,810 29,075
Cost of products sold 4,296 3,978 8,686 7,998
Selling, marketing and administrative expenses 3,130 2,789 6,048 5,050
Research and development expense 2,875 2,869 5,688 5,417
Other (income) expense, net (166) 14 (178) (152)
Earnings before provision for taxes on income 6,249 5,552 11,566 10,762
Amortization 800 800 1,500 1,400
Operating Segments | MedTech        
Segment Reporting [Line Items]        
Restructuring (Note 12) 17 50 24 105
Sales to customers (Note 9) 8,926 8,541 17,562 16,561
Cost of products sold 3,737 3,638 7,438 6,964
Selling, marketing and administrative expenses 3,069 2,862 5,975 5,518
Research and development expense 778 647 1,492 1,324
Other (income) expense, net 165 190 241 130
Earnings before provision for taxes on income 1,177 1,204 2,416 2,625
Amortization $ 500 $ 500 $ 1,000 $ 1,000